Tokyo, Nov. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059655) titled 'Development and Evaluation of a Leaflet to Support Patients in Reviewing Their Medications Together with Healthcare Providers' on Nov. 5.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - Active

Primary Sponsor: Institute - St. Marianna University School of Medicine

Condition: Condition - Patients with polypharmacy Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study aims to establish the foundation of the MPEG Plus program, which supports autonomous decision-making by patients with polypharmacy and promotes medication review. To achieve this, a patient leaflet based on nudge theory will be developed to encourage patients to consult healthcare providers about their medications, and its acceptability and usefulness will be evaluated through an online randomized controlled trial involving both patients and healthcare professionals. Basic objectives2 - Others

Intervention: Interventions/Control_1 - Viewing of a Medication Review leaflet designed based on nudge theory Interventions/Control_2 - Viewing of a general leaflet designed based on the Health Belief Model

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - [Online RCT for Patients] Adults (aged 18 years or older) who are registered monitors of Macromill Inc. and are prescribed five or more regular medications by a healthcare institution, and who have provided voluntary informed consent to participate in this study after receiving sufficient explanation about its purpose and content.

[Online RCT for Healthcare Professionals] Licensed physicians or pharmacists who have provided voluntary informed consent to participate in this study after receiving sufficient explanation about its purpose and content. Key exclusion criteria - Individuals deemed inappropriate for inclusion by the principal investigator Target Size - 400

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 10 Month 31 Day Date of IRB - 2025 Year 10 Month 31 Day Anticipated trial start date - 2025 Year 12 Month 01 Day Last follow-up date - 2027 Year 02 Month 28 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068238

Disclaimer: Curated by HT Syndication.